HomeCompareMDT vs APD

MDT vs APD: Dividend Comparison 2026

MDT yields 3.31% · APD yields 2.46%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APD wins by $30.1K in total portfolio value· pulled ahead in Year 5
10 years
MDT
MDT
● Live price
3.31%
Share price
$85.74
Annual div
$2.84
5Y div CAGR
29.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$54.3K
Annual income
$9,789.15
Full MDT calculator →
APD
APD
● Live price
2.46%
Share price
$291.56
Annual div
$7.16
5Y div CAGR
42.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84.4K
Annual income
$25,407.75
Full APD calculator →

Portfolio growth — MDT vs APD

📍 APD pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDTAPD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDT + APD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDT pays
APD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDT
Annual income on $10K today (after 15% tax)
$281.55/yr
After 10yr DRIP, annual income (after tax)
$8,320.78/yr
APD
Annual income on $10K today (after 15% tax)
$208.74/yr
After 10yr DRIP, annual income (after tax)
$21,596.59/yr
At 15% tax rate, APD beats the other by $13,275.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDT + APD for your $10,000?

MDT: 50%APD: 50%
100% APD50/50100% MDT
Portfolio after 10yr
$69.3K
Annual income
$17,598.45/yr
Blended yield
25.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MDT right now

MDT
Analyst Ratings
1
Strong
26
Buy
22
Hold
Consensus: Buy
Price Target
$111.45
+30.0% upside vs current
Range: $100.00 — $120.00
Altman Z
2.9
Piotroski
7/9
APD
Analyst Ratings
23
Buy
19
Hold
Consensus: Buy
Price Target
$296.33
+1.6% upside vs current
Range: $255.00 — $335.00
Altman Z
2.6
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDT buys
0
APD buys
0
No recent congressional trades found for MDT or APD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDTAPD
Forward yield3.31%2.46%
Annual dividend / share$2.84$7.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29.3%42.5%
Portfolio after 10y$54.3K$84.4K
Annual income after 10y$9,789.15$25,407.75
Total dividends collected$29.9K$58.3K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$111.45$296.33

Year-by-year: MDT vs APD ($10,000, DRIP)

YearMDT PortfolioMDT Income/yrAPD PortfolioAPD Income/yrGap
1$11,128$428.29$11,050$349.95+$78.00MDT
2$12,483$575.94$12,338$514.98+$145.00MDT
3$14,138$780.71$13,968$765.81+$170.00MDT
4$16,196$1,068.46$16,100$1,154.58+$96.00MDT
5← crossover$18,809$1,479.09$19,000$1,772.38$191.00APD
6$22,201$2,075.70$23,115$2,785.49$914.00APD
7$26,716$2,960.69$29,246$4,513.18$2.5KAPD
8$32,891$4,305.30$38,898$7,604.83$6.0KAPD
9$41,599$6,405.16$55,092$13,470.41$13.5KAPD
10$54,300$9,789.15$84,356$25,407.75$30.1KAPD

MDT vs APD: Complete Analysis 2026

MDTHealthcare

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Full MDT Calculator →

APDMaterials

Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, manufacturing, food and beverage, electronics, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. has a strategic collaboration with Baker Hughes Company to develop hydrogen compression systems. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.

Full APD Calculator →
📬

Get this MDT vs APD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDT vs SCHDMDT vs JEPIMDT vs OMDT vs KOMDT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.